OncasparActive Ingredient(s): Pegaspargase
FDA Approved: * February 1, 1994
Pharm Company: * ENZON
Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and prednisone. It is used by injection. Common side effects include allergic reactions, blood clotting problems, high blood sugar, liver problems, pancreas inflammation, and blood clots in the brain. Its use during pregnancy may harm ... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, SolutionNDC: 0944-3810
Baxalta Us Inc.
Oncaspar 750 [iu]/Ml Intramuscular; Intravenous Injection, SolutionNDC: 54482-301
Sigma-tau Pharmaceuticals, Inc.
Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, SolutionNDC: 72694-954